Penumbra, Inc. (PEN)
326.65
+4.33
(+1.34%)
USD |
NYSE |
May 18, 16:00
326.65
0.00 (0.00%)
After-Hours: 16:51
Penumbra Research and Development Expense (Quarterly) : 17.99M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 516.00M |
| Abbott Laboratories | 767.00M |
| Insulet Corp. | 89.70M |
| Globus Medical, Inc. | 36.51M |
| Intuitive Surgical, Inc. | 361.60M |